Dermavance Pharmaceuticals

Zydus Pharmaceuticals USA Inc. is a leading generic pharmaceutical company in the US, offering a wide range of FDA-approved medications to help patients treat and manage diseases, fight infections, and improve overall health and wellness. With a commitment to saving and improving lives, Zydus Pharmaceuticals is the US generic drug division of Zydus Lifesciences, a global pharmaceutical company present in 50 countries, dedicated to growing its presence worldwide. Providing high-quality and affordable generics, Zydus Pharmaceuticals ensures that their products work in the same way as their brand-name counterparts, as they use the same active ingredients, offering the same benefits and risks. With a strong focus on patient care and a mission to support global healthcare, Zydus Pharmaceuticals is dedicated to delivering outstanding service and making a positive impact on patients' lives.Generated from the website

CSL Behring is one of the leading providers of plasma protein biotherapeutic products in the world. It is a pharmaceutical company engaged in the research and development of life-saving biotherapies for the treatment of coagulation disorders, such as hemophilia and von Willebrand diseases. The company additionally manufactures a variety of medicines and drugs for the treatment of immune deficiencies, genetic emphysema, sepsis, severe burns, wounds and heomolytic diseases. It also provides medicines for transplantation, coagulation, immunology and critical care applications. The company supplies products under the Cytogam, Helixate, Humate-P, Monoclate-P, Mononine, Stimate, AlbuRx, Albuminar and Vivaglobin brands. It offers sales, marketing, distribution, online ordering and customer support services. The company maintains CSL Plasma, which is a plasma collection network that operates throughout the United States and Germany. CSL Behring is a part of CSL Limited, which is an Australia-based company that supplies sera and vaccines.

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers throughout the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, as well as ophthalmic surgical and pharmaceutical products. Founded in 1853, the company is headquartered in Rochester, N.Y. Bausch & Lomb s 2004 revenues were $2.2 billion, and it employs approximately 12,400 people worldwide. The company s products are available in more than 100 countries. Bausch & Lomb s Vision Care business manufactures and markets some of the world s most comprehensive lines of eye care products.